Advanced Filters
noise

Occlusions Clinical Trials

A listing of Occlusions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 518 clinical trials
S Solange HESSE

Video-oculography and Parkinson's Disease

This study aims to study, in patient with Parkinson's disease, mild to moderate stage (according to Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease, Postuma et al., 2015): the evolution of oculomotricity markers over time. the correlation between neurological evaluations (motor and non-motor scores), neuropsychological evaluations (cognitive disorders) and …

18 - 100 years of age Both Phase N/A
J Jennifer Mule, BS

TAME-PD - Physical Therapy, Atomoxetine And, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

Gait and balance problems are a significant source of disability in patients with Parkinson disease. Physical therapy remains one of the main treatments. On the other hand some medications, such as methyphenidate and atomoxetine, have been tried with promising results. The outcomes in gait and balance in Parkinson disease after …

18 - 90 years of age Both Phase N/A

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

This study is being done to understand how reducing blood flow (BRT) during balance-challenging strengthening exercises (instability resistance training, or IRT) can help improve symptoms of Parkinson's disease.

40 - 85 years of age Both Phase N/A
A Angela Leung, PhD

Voice-activated Intelligent Personal Assistant (VIPA) Intervention for People With Parkinson's Disease

This pilot randomized control trial (RCT) aims to develop a Voice-activated Intelligent Personal Assistance (VIPA) user protocol and study its feasibility and preliminary efficacy among 60 People with Parkinson's disease (PWP). The research questions are: Phase 1: What components should be included in the VIPA user protocol community-dwelling PWP? Is …

18 - 100 years of age Both Phase N/A
C Caroline Wagandt, BA

Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease. Participants will be asked to complete up to 5 in-person study visits over approximately 20 weeks. Participants will receive both AGB101 and a placebo to take once a …

40 - 85 years of age Both Phase 2
C Chun-Feng Liu, Ph.D, MD

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease

A safety study in patients with Parkinson's disease.

45 - 70 years of age Both Phase N/A

Aim 3 Particle Swarm Optimization PIGD

In Parkinson's disease (PD) patients undergoing standard-of-care Deep Brain Stimulation (DBS) therapy, to compare the effect on Parkinson's symptoms of two different neurostimulator settings designed to differ from each other as much as possible with respect to how much they activate two different neuroanatomical structures: the axonal pathway from Globus …

18 - 85 years of age Both Phase N/A
W Won Hyuk Chang, Prof

Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients

The objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each patient with Parkinson's disease, compared to conventional high-frequency rTMS therapy on bilateral primary motor cortex (M1). Investigators hypothesized that the functional reserve of each …

50 - 100 years of age Both Phase N/A
H Hsien-Yuan Lane, M.D., Ph.D

Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

Alzheimer's disease (AD) and Parkinson's disease (PD) are currently the leading neurodegenerative disorders. Considering the fact that aged population is rapidly growing, it has become a critical issue to find more effective medications for these two disorders. The aim of this project is to examine the effectiveness and safety of …

50 - 90 years of age Both Phase 2
C Caroline SANDRE-BALLESTER, PhD

Preparation and Feasibility of Exams for Expected Studies

Feasibility study: the examinations carried out as part of this protocol aim to carry out all the acquisitions and simulations of use, necessary for the development of the clinical research protocols to come to Clinatec (in particular, configuration of the equipment, dimension of the examination time and the size of …

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI